We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
3176
CALL
Nike
NKE
$61.9B
$9K ﹤0.01%
23,200
-26,900
-54% -$1.38M
VNQ icon
3177
CALL
Vanguard Real Estate ETF
VNQ
$39.1B
$9K ﹤0.01%
22,100
-4,900
-18% -$399K
KSU
3178
CALL
DELISTED
Kansas City Southern
KSU
$9K ﹤0.01%
+10,200
New +$899K
THM
3179
International Tower Hill Mines
THM
$604M
$8K ﹤0.01%
15,000
XOM icon
3180
CALL
ExxonMobil
XOM
$634B
$8K ﹤0.01%
16,600
-12,500
-43% -$1.09M
BNFT
3181
CALL
DELISTED
Benefitfocus, Inc.
BNFT
$8K ﹤0.01%
13,000
+2,000
+18% +$63.8K
GSS
3182
DELISTED
Golden Star Resources Ltd.
GSS
$8K ﹤0.01%
2,200
GDXJ icon
3183
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$7K ﹤0.01%
10,400
-700
-6% -$25.4K
OPK icon
3184
CALL
Opko Health
OPK
$1.02B
$7K ﹤0.01%
65,000
V icon
3185
CALL
Visa
V
$677B
$7K ﹤0.01%
26,100
-4,600
-15% -$370K
AMJ
3186
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$7K ﹤0.01%
+27,600
New +$843K
FCX icon
3187
CALL
Freeport-McMoran
FCX
$97.5B
$6K ﹤0.01%
65,500
-48,400
-42% -$619K
RTX icon
3188
CALL
RTX Corp
RTX
$301B
$6K ﹤0.01%
+40,520
New +$2.69M
CDMO
3189
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$6K ﹤0.01%
2,937
BHC icon
3190
CALL
Bausch Health
BHC
$2.34B
$5K ﹤0.01%
39,500
-57,000
-59% -$1.05M
POT
3191
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
$5K ﹤0.01%
10,800
EEM icon
3192
CALL
iShares MSCI Emerging Markets ETF
EEM
$30B
$4K ﹤0.01%
47,400
-1,500
-3% -$54.1K
ICE icon
3193
CALL
Intercontinental Exchange
ICE
$84.4B
$4K ﹤0.01%
+18,500
New +$1.02M
OMER icon
3194
CALL
Omeros
OMER
$959M
$4K ﹤0.01%
19,800
-33,300
-63% -$340K
OMF icon
3195
CALL
OneMain Financial
OMF
$7.47B
$4K ﹤0.01%
89,200
-1,400
-2% -$34.4K
GCVRZ
3196
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$4K ﹤0.01%
11,093
-256
-2% -$87
ARLP icon
3197
CALL
Alliance Resource Partners
ARLP
$3.17B
$3K ﹤0.01%
+12,100
New +$284K
HSBC icon
3198
CALL
HSBC
HSBC
$356B
$3K ﹤0.01%
15,387
+1,107
+8% +$39.2K
QQQ icon
3199
CALL
Invesco QQQ Trust
QQQ
$481B
$3K ﹤0.01%
+11,200
New +$1.32M
UAA icon
3200
CALL
Under Armour
UAA
$2.6B
$3K ﹤0.01%
+34,700
New +$1.14M

Similar funds

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.